Skip to content

Active ingredient

Bimatoprost

28 finished FDA listings contain Bimatoprost as their only active ingredient.

FDA NDC Directory

Ingredient names as written by FDA
BIMATOPROST
Dosage forms
Gel, Implant, Solution/ Drops
Routes
Intracameral, Ophthalmic
Manufacturers / labelers
15
Strengths listed
.1 mg/g · .1 mg/ml · .3 mg/ml · 10 ug/1
Brand names in FDA listings
Durysta, Latisse, Lumigan, Zolymbus

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 283810

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 022369ABBVIE2008-12-241
NDA 022184ABBVIE2010-08-311
ANDA 090449APOTEX2015-07-201
ANDA 202719SANDOZ2016-04-191
ANDA 210126GLAND2019-03-227
ANDA 210263ALEMBIC2019-04-122
ANDA 207601SOMERSET THERAPS LLC2019-06-193
ANDA 210515ALEMBIC2020-01-212
NDA 211911ABBVIE2020-03-041
ANDA 202505MICRO LABS2020-09-082
ANDA 205537EUGIA PHARMA2022-10-061
ANDA 218196MANKIND PHARMA2025-03-174
NDA 217307THEA PHARMA2025-09-091
ANDA 217289AMNEAL2025-09-221

Official labeling on DailyMed

Showing the 12 most recent of 20 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.